Initiative / High-Risk Myocardial Infarction Database Initiative

High-Risk Myocardial Infarction Database Initiative
  1. Home
  2. Initiatives
  3. High-Risk Myocardial Infarction Database Initiative

High-Risk Myocardial Infarction Database Initiative

Studies 4
The primary objectives of this initiative were to use this large database to define more precisely the prognostic profile of this high risk population and to perform rigorous subset analyses. The information has been extracted from the article: Dickstein, Kenneth, Judith Bebchuk, and Janet Wittes. "The high-risk myocardial infarction database initiative." Progress in cardiovascular diseases 54.4 (2012): 362-366.
Information status
Some important information is missing

Members

Affiliated Members
Investigators Contacts
  • Kenneth Dickstein
    Stavanger Health Research

General Information

Types of cohorts
  • Clinical trial
Region
Australia, Eastern Europe, Israel, Latin America, North America, New Zealand, South Africa, South Korea, Taiwan, Western Europe .
Setting
International
Funding
The original budget for creating the common database was approximately US200,000. No public source was willing to provide funding, so individual members of the Scientific Committee made contributions from local research funds.
Criteria of cohort's to be included
Randomized, controlled, double-blind clinical trials that evaluated a pharmacologic intervention in highrisk patients following acute myocardial infarction complicated with signs of heart failure or evidence of left ventricular dysfunction.
Health topic
  • Cardiovascular diseases
  • General epidemiology
Socio-environmental context
  • NA

Participants

Number of participants

Total
28,771
With harmonized data
28,771

Age range of the samples

Minimum age
18
Maximum age
150

Methodology for harmonization and integration

Strategy of harmonization
Ex-post
Data processing methods
  • NA
    • Type of infrastructure
    NA
    Integrative data analysis
    • Meta-analyses
    • Pooled analyses
    Software
  • R / Rmarkdown
  • SAS

    • Number of cohorts

    Total
    4
    With harmonized data
    4
    Will more cohorts be harmonized?
    Number of harmonized variables (max.)
    18

    Access

    Availability of metadata
    Availability of individual data
    Under request

    Individual Studies

    Acronym Name Study design Participants Countries
    CAPRICORN Cardvedilol Post Infarct Survival Control in Left Ventricular Dysfunction Clinical trial 1,959
    EPHESUS Eplerenone Post Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Clinical trial cohort 6,632
    OPTIMAAL Optimal Trial in Myocardial Infarction with Angiotension II Antogonist, Losartan Clinical trial cohort 5,477
    VALIANT Valsartan in Acute Myocardial Infarction Clinical trial cohort 14,703